GUIDANT CONTAK RENEWAL FAMILY OF CARDIAC RESYNCHRONIZATION THERAPY DEVICES

Cardiac related image

A Cardiac Resynchronization Therapy Devices Related Image

(Not Necessarily related to the device)

Description:

GUIDANT CONTAK RENEWAL FAMILY OF CARDIAC RESYNCHRONIZATION THERAPY DEVICES by Boston Scientific Corp.

The Guidant Contak Renewal family of cardiac resynchronization therapy devices represent a significant evolution in the treatment of heart failure. This series of devices are designed with the purpose of improving cardiac function and the patient's quality of life.

The primary function of these devices is to resynchronize the beating of the heart's chambers, which, in turn, enhances the overall efficiency of the heart. By achieving equilibrium between the contractions of the heart's lower chambers, these devices can help alleviate a key symptom of heart failure - shortness of breath.

Benefits:

1. Improved Cardiac Function: Resynchronization reduces the workload of the heart and improves its pumping efficiency.

2. Enhanced Quality of Life: With improved heart function, patients experience less fatigue and shortness of breath, leading to a significant improvement in daily living activities and overall life quality.

3. Prolonged Survival: Studies have shown that the use of cardiac resynchronization therapy devices can contribute to prolonged life expectancy by reducing the risk of sudden cardiac death.

Overall, the Guidant Contak Renewal family of devices offers a comprehensive solution that addresses the root causes and symptoms of heart failure and improves patient outcomes, thereby revolutionizing the standard of care in heart health.

Primary Use:

Primary Medical Use of GUIDANT CONTAK RENEWAL FAMILY OF CARDIAC RESYNCHRONIZATION THERAPY DEVICES

The GUIDANT CONTAK RENEWAL FAMILY OF CARDIAC RESYNCHRONIZATION THERAPY DEVICES is a high-tech pacemaker system that is exponentially improving the lives of millions across the globe. The primary function of this device is to provide Cardiac Resynchronization Therapy (CRT).
CRT is an efficient therapeutic solution designed for heart failure patients who are experiencing ventricular dysynchrony. Ventricular dysynchrony occurs when different parts of the heart ventricles do not contract simultaneously, leading to ineffective heart-pumping functionality.

How It Works

The GUIDANT CONTAK RENEWAL CRT device works by emitting small electrical impulse

How It Works:

The Guidant Contak Renewal Family of Cardiac Resynchronization Therapy Devices

The Guidant Contak Renewal Family of Cardiac Resynchronization Therapy Devices (CRTDs) are innovative pacemakers designed to address the needs of patients with heart failure and associated conditions. These devices are monumental in their ability to restore synchronous contractility to the ventricles, thus enhancing overall cardiac efficiency.

Operating Principle

These devices function utilizing the principle of cardiac resynchronization. In patients with heart failure, dyssynchronous ventricular contractions are often a significant issue, contributing to the disease's progressive nature. The Guidant Contak Renewal CRTDs work by delivering synchronized electrical impulses to both the left and right ventricles. This biventricular pacing mechanism helps to normalize the interaction between the ventricles, improving cardiac efficiency and patient symptoms.

Incorporated Technology

In addition, these devices incorporate advanced sensory and adaptive technologies. They possess an atrial sensing ventricular pacing feature that works in harmony with the patient's natural heart rhythms, ultimately leading to more physiological pacing. Additionally, the Guidant Contak Renewal CRTDs have an elegantly designed rate-responsive algorithm that can adjust heart pacing rates according to the patient's metabolic demands. This feature affords patients the utmost comfort and improved quality of life.

Defibrillation Capability

A critical feature to note is the in-built defibrillation capability. These devices incorporate modern defibrillation technology which can deliver a life-saving shock in events of ventricular tachycardia or fibrillation, thus serving a dual function as an Implantable Cardioverter Defibrillator (ICD). To summarize, the Guidant Contak Renewal Family of CRTDs can significantly improve the quality of life and survival rates of heart failure patients by incorporating biventricular pacing, advanced sensing technology, and defibrillation capabilities into one singular device. These key features underline its distinctiveness in the current landscape of pacemaker devices and cement its position as an invaluable tool in modern cardiac care.

Manufacturer:

Boston Scientific Corp.

Status: In Stock

Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.